SAE1 and cancer: A parallel between the clinical course of myositis and cancer was observed in patients carrying anti-TIF1, anti-NXP2, anti-SAE1, anti-Jo-1, anti-PL-12, and anti-HMGCR antibodies, and in the MSAs- patients (Table 3).